Browse all articles

Showing 1201–1250 of 4,273

Search

Metabolic syndrome in women with polycystic ovary syndrome

Chandrasekaran S et al. 2018 The Obstetrician & Gynaecologist

Key content The risk factors for metabolic syndrome include central obesity, hypertension, atherogenic dyslipidaemia and insulin resistance. Metabolic syndrome affects 33% of women with polycystic ova...

Metabolic SyndromeCardiometabolic Risk AssessmentLifestyle Modification

Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization

Toljan K et al. 2018 Open Access Medical Sciences (Basel, Switzerland)

Naltrexone and naloxone are classical opioid antagonists. In substantially lower than standard doses, they exert different pharmacodynamics. Low-dose naltrexone (LDN), considered in a daily dose of 1 ...

Low-Dose Naltrexone Therapeutic ReviewOpioid Antagonist TherapyOff-Label Drug Applications

Association of oral contraceptive use with suicidal behavior among representative Korean population: Results from Korea National Health and Nutrition Examination Survey (2007-2016)

Jung SJ et al. 2018 Journal of Affective Disorders

Introduction: The association of suicide with the use of oral contraceptives (OC) is unknown in the Asian population. We aimed to evaluate the association of OC use and suicidal behavior in a national...

Mental Health Side EffectsSuicidality RiskCross-Sectional Survey

The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions

Munro MG et al. 2018 Open Access International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics

Background: The International Federation of Gynecology and Obstetrics (FIGO) systems for nomenclature of symptoms of normal and abnormal uterine bleeding (AUB) in the reproductive years (FIGO AUB Syst...

Classification SystemsFIGO StandardsAbnormal Uterine Bleeding

Current Medical Research: Summer/Fall 2017

Fehring RJ et al. 2018 The Linacre Quarterly

This issue of Current Medical Research (CMR) includes studies that provide evidence that use of natural family planning (NFP) can be helpful for subfertile couples wishing to achieve a pregnancy, the ...

Quarterly Evidence SummaryNFP Subfertility ApplicationsBreastfeeding Method Effectiveness

Photobiomodulation: lasers vs. light emitting diodes?

Heiskanen V et al. 2018 Open Access Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology

Photobiomodulation (PBM) is a treatment method based on research findings showing that irradiation with certain wavelengths of red or near-infrared light has been shown to produce a range of physiolog...

Laser vs LED Therapy ComparisonLight-Based TherapeuticsPhotobiomodulation Applications

Low Dose Naltrexone in the Treatment of Fibromyalgia

Metyas SK et al. 2018 Current Rheumatology Reviews

Background: ConclusionFibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleep disturbance and cognitive impairment. Objective: A significant number of fi...

Self-Monitoring of Fertility Hormones: A New Era for Natural Family Planning?

Blackwell L et al. 2018 The Linacre Quarterly

Natural family planning (NFP) methods have served many generations well, and in particular, the symptothermal or symptohormonal methods. The comparison of daily mucus and temperature records for indiv...

Home Fertility Hormone MonitoringUrinary Hormone Self-TestingQuantitative Home Immunoassay

Progesterone for treatment of symptomatic menopausal women

Prior JC 2018 Climacteric : the Journal of the International Menopause Society

This review's purpose is to highlight evidence that oral micronized progesterone (progesterone) is effective for hot flushes and night sweats (vasomotor symptoms, VMS), improves sleep and is likely sa...

Progesterone TherapyVasomotor Symptom ManagementHormone Therapy Breast Cancer Risk

Progesterone for the prevention and treatment of osteoporosis in women

Prior JC 2018 Open Access Climacteric : the Journal of the International Menopause Society

Estradiol (E2) is women's dominant 'bone hormone' since it is essential for development of adolescent peak bone mineral density (BMD) and physiological levels prevent the rapid (3-week) bone resorptio...

Progesterone TherapyBone FormationBone Mineral Density Impact

Update on male reproductive endocrinology

Clavijo RI et al. 2018 Translational andrology and urology

Practitioners of male reproductive and sexual medicine must have an intimate understanding of the physiology of male reproductive endocrinology, as such a knowledge is the cornerstone on which hormona...

Current and emerging treatment options for endometriosis

Ferrero S et al. 2018 Expert opinion on pharmacotherapy

INTRODUCTION: Pharmacotherapy has a pivotal role in the management of endometriosis with long-term treatments balancing clinical efficacy (control of pain symptoms and prevention of recurrence of the ...

Vertebral Fractures and Morphometric Deformities

Brian C Lentle et al. 2018 J Bone Miner Res

To the Editor: We read with interest the editorial by Cummings and Eastell,1 A History of Pivotal Advances in Clinical Research in Bone and Mineral Diseases, published in a recent issue of the JBMR. I...

Vertebral Morphometry MethodsVertebral Fracture AssessmentOsteoporotic Fracture Classification

Hormonal Predictors of Abnormal Luteal Phases in Normally Cycling Women

Abdulla SH et al. 2018 Open Access Frontiers in Public Health

Objective: Explore potential relationships between preovulatory, periovulatory, and luteal-phase characteristics in normally cycling women. Design: Observational study. Setting: Eight European natural...

Hormonal Predictors of DeficiencyPreovulatory-Luteal Phase RelationshipsCycle Hormone Pattern Analysis

Women's Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)

Wong EMM et al. 2018 Open Access International Journal of Environmental Research and Public Health

Women's hot flushes and night sweats, collectively called vasomotor symptoms (VMS), are maximal (79%) in late perimenopause. The evidence describing whether VMS are associated with loss of areal bone ...

Bone Density Loss AssociationNight Sweats and BMD ChangesCanadian Multicentre Osteoporosis

Combined hormonal contraceptives use and bone mineral density changes in adolescent and young women in a prospective population-based Canada-wide observational study

Brajic TS et al. 2018 Journal of Musculoskeletal & Neuronal Interactions

Objectives: To assess combined hormonal contraceptives (CHC) use and adolescent women's peak areal bone mineral density (BMD) accrual. Methods: We enrolled 527 randomly selected women across Canada (...

Population-Based Prospective EvidenceSkeletal Health OutcomesCanadian Multicentre Study

Progesterone and women's anxiety across the menstrual cycle

Reynolds TA et al. 2018 Hormones and behavior

Animal models and a few human investigations suggest progesterone may be associated with anxiety. Progesterone naturally fluctuates across the menstrual cycle, offering an opportunity to understand ho...

Adult Premenopausal Bone Health Related to Reproductive Characteristics-Population-Based Data from the Canadian Multicentre Osteoporosis Study (CaMos)

Goshtasebi A et al. 2018 Open Access International Journal of Environmental Research and Public Health

Amenorrhea is important for women's bone health. However, few have reported reproductive, anthropometric (body mass index [BMI], height) and bone health (areal bone mineral density [BMD], prevalent fr...

Premenopausal BMD DeterminantsBone Density ConsequencesCaMos Reproductive Data

Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women

Jerilynn C Prior et al. 2018 Open Access International Journal of Environmental Research and Public Health

Approximately 33% of normal-length (21⁻35 days) cycles have subclinical ovulatory disturbances and lack sufficient progesterone, although their normal length ensures enough estrogen. Subclinical ovula...

Molimina Diagnostic UtilityPremenstrual Symptoms and OvulationDetection

Oxidative Stress in Preeclampsia and Placental Diseases

Aouache R et al. 2018 International journal of molecular sciences

Preeclampsia is a persistent hypertensive gestational disease characterized by high blood pressure and proteinuria, which presents from the second trimester of pregnancy. At the cellular level, preecl...

Can apps and calendar methods predict ovulation with accuracy?

Johnson S et al. 2018 Current Medical Research and Opinion

Objective: The accuracy of prediction of ovulation by cycle apps and published calendar methods was determined by comparing to true probability of ovulation. Methods: A total of 949 volunteers collec...

Calendar and App-Based MethodsLH Surge and Cycle Length VariabilityCycle Tracking App Accuracy
All 86 pages